PRVA
Privia Health Group, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$20.66
−0.05%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.4B | 2.1B | 1.7B | 1.7B | 1.4B |
| Cost of Revenue | 2.2B | 1.9B | 1.6B | 1.5B | 1.2B |
| Gross Profit | 179.5M | 209.4M | 176.9M | 161.5M | 134.8M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 49.7B | 165.3M | 152.6M | 134.3M | 149.3M |
| General & Admin Expense | 41.6B | 138.2M | 126.2M | 109.6M | 129.6M |
| Selling & Marketing Expense | 8.2B | 27.1M | 26.4M | 24.7M | 19.7M |
| Other Expenses | (49.6B) | 9.9M | 7.3M | 6.5M | 4.6M |
| Total Operating Expenses | 134.6M | 175.2M | 159.9M | 140.9M | 153.9M |
| Cost and Expenses | 2.3B | 2.1B | 1.7B | 1.6B | 1.4B |
| Operating Income (EBIT) | 44.9M | 34.2M | 17.0M | 20.6M | (19.1M) |
| Non-Operating | |||||
| Interest Income | 6.3M | 9.7M | 10.9M | 8.4M | 542.0K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 6.3M | 9.7M | 10.9M | 8.4M | 542.0K |
| Other Non-Op Income/Expense | 11.2M | 9.7M | 10.9M | 8.4M | 542.0K |
| Non-Operating Income (excl Interest) | (11.2M) | (9.7M) | (10.9M) | (8.4M) | (542.0K) |
| EBT (Pre-Tax Income) | 56.1M | 43.9M | 27.9M | 29.0M | (18.6M) |
| Income Tax Expense | 22.3M | 14.2M | 10.8M | 8.0M | (6.5M) |
| Bottom Line | |||||
| Net Income | 28.1M | 22.9M | 14.4M | 23.1M | (8.6M) |
| Earnings from Cont. Ops | 33.8M | 29.7M | 17.0M | 21.0M | (12.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 28.1M | 22.9M | 14.4M | 23.1M | (8.6M) |
| Per Share | |||||
| Basic EPS | $0.22 | $0.19 | $0.12 | $0.20 | ($0.08) |
| Diluted EPS | $0.22 | $0.18 | $0.11 | $0.19 | ($0.08) |
| Revenue Per Share | $18.70 | $17.38 | $14.54 | $14.20 | $12.26 |
| Shares | |||||
| Basic Shares Outstanding | 126.1M | 122.2M | 119.4M | 116.7M | 110.7M |
| Diluted Shares Outstanding | 131.8M | 128.9M | 125.6M | 124.7M | 110.7M |
| Profitability Metrics | |||||
| EBITDA | 68.2M | 53.8M | 35.1M | 35.6M | (14.0M) |
| D&A | 12.1M | 9.9M | 7.3M | 6.5M | 4.6M |
| EBIT | 56.1M | 43.9M | 27.9M | 29.0M | (18.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026